Founded in 1989, Cryo-Cell International Inc. is the world’s first private cord blood bank. More than 500,000 parents from 87 countries have entrusted Cryo-Cell International with their baby’s cord blood and cord tissue stem cells. In addition to its family bank, Cryo-Cell International has a public banking program in partnership with Duke University. Cryo-Cell’s public bank has provided cord blood for more than 600 transplantations and operates cord blood donation sites across the U.S in prominent hospitals such as Cedars–Sinai Hospital in Los Angeles and Baptist Hospital in Miami. Cryo-Cell’s mission is to provide clients withstate-of-the-art cord blood and cord tissue cryopreservation services, raise awareness of the opportunity for expectant parents to bank or donate their baby’s cord blood and support the advancement of regenerative medicine. Cryo-Cell operates in a facility that is FDA registered, cGMP-/cGTP-compliant and licensed in all states requiring licensure. Besides being AABB accredited as a cord blood facility, Cryo-Cell was also the first U.S. (for private use only) cord blood bank to receive FACT accreditation for adhering to the most stringent cord blood quality standards set by any internationally recognized, independent accrediting organization. In addition, Cryo-Cell is ISO 13485:2003–certified by TÜV, an internationally recognized, quality assessment organization. Cryo-Cell is a publicly traded company, OTCQB:CCEL. For more information, please visit www.cryo-cell.com.
Company profile
Ticker
CCEL
Exchange
Website
CEO
Mark L. Portnoy / David I. Portnoy
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
SEC CIK
Corporate docs
IRS number
223023093
CCEL stock data
Calendar
27 Apr 22
26 Jun 22
30 Nov 22
Financial summary
| Quarter (USD) | Feb 22 | Nov 21 | Aug 21 | May 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Nov 21 | Nov 20 | Nov 19 | Nov 18 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 2.14M | 2.14M | 2.14M | 2.14M | 2.14M | 2.14M |
| Cash burn (monthly) | 2.04M | 761.1K | (no burn) | (no burn) | (no burn) | (no burn) |
| Cash used (since last report) | 8.1M | 3.02M | n/a | n/a | n/a | n/a |
| Cash remaining | -5.96M | -879.41K | n/a | n/a | n/a | n/a |
| Runway (months of cash) | -2.9 | -1.2 | n/a | n/a | n/a | n/a |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 8 Apr 22 | Portnoy Mark L. | Stock Option Common Stock | Grant | Acquire A | No | No | 12.27 | 100,000 | 1.23M | 100,000 |
| 8 Apr 22 | Portnoy Mark L. | Stock Option Common Stock | Grant | Acquire A | No | No | 13.5 | 20,000 | 270K | 20,000 |
| 8 Apr 22 | Portnoy David | Stock Option Common Stock | Grant | Acquire A | No | No | 12.27 | 280,000 | 3.44M | 280,000 |
| 8 Apr 22 | Portnoy David | Stock Option Common Stock | Grant | Acquire A | No | No | 12.27 | 553 | 6.79K | 553 |
| 8 Apr 22 | Portnoy David | Stock Option Common Stock | Grant | Acquire A | No | No | 13.5 | 24,447 | 330.03K | 24,447 |
| 28 Dec 21 | Oleg Mikulinsky | Stock Option Common Stock | Grant | Acquire A | No | No | 11.9 | 20,000 | 238K | 20,000 |
| 22 Dec 21 | Portnoy Mark L. | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 12.27 | 100,000 | 1.23M | 0 |
| 22 Dec 21 | Portnoy Mark L. | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 13.5 | 20,000 | 270K | 0 |
| 22 Dec 21 | Portnoy David | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 12.27 | 280,000 | 3.44M | 0 |
| 22 Dec 21 | Portnoy David | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 12.27 | 553 | 6.79K | 0 |
Institutional ownership, Q4 2021
16.4% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 15 |
| Opened positions | 4 |
| Closed positions | 0 |
| Increased positions | 3 |
| Reduced positions | 5 |
| 13F shares | Current |
|---|---|
| Total value | 137.6M |
| Total shares | 1.39M |
| Total puts | 0 |
| Total calls | 0 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Iszo Capital | 482.93K | $0 |
| Iszo Capital Management | 482.93K | $5.6M |
| SFI Advisors | 165.3K | $1.57M |
| Massmutual Trust Co FSB | 76.04K | $882K |
| Vanguard | 72.24K | $838K |
| Seizert Capital Partners | 43.48K | $504K |
| Maryland Capital Management | 19.56K | $227K |
| HighTower Advisors | 13.76K | $160K |
| Millennium Management | 12.74K | $148K |
| Rowland & Co Investment Counsel | 11K | $127.6M |
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
AABB, abandon, accelerated, accidental, accommodate, accomplish, accreditation, accurate, accurately, addressed, adequate, adequately, adulteration, advantage, advisory, advocacy, ago, aid, alleviate, allogeneic, American, analyze, anti, appealing, area, Arizona, arm, assignment, assimilate, assist, attack, attempt, attempted, attempting, attended, attention, attestation, attorney, attract, attractive, attrition, avoid, baby, bag, Bay, behalf, behavioral, beneficial, beneficially, billed, biography, biologic, biological, biomedical, biopharma, biorepository, birth, BLA, blinded, Blvd, body, born, brand, bring, broad, Brooker, brought, building, bulk, bunker, California, call, called, campaign, cancer, candidate, capable, capacity, care, caregiver, cartilage, CBER, cease, certificate, certified, CFR, cGMP, chance, Chancery, charter, chemotherapy, childbirth, China, civil, claim, claimed, claiming, clearance, cleared, code, codified, coercive, cold, combination, commence, commenced, commencement, commented, commerce, committee, commodity, communicable, compelled, complex, composed, concentration, concurrent, condominium, conduct, conducted, confidence, confidential, confidentiality, confidentially, conflict, conflicting, consecutive, consent, constantly, constructed, constructing, construction, construed, consulting, contact, contamination, cooperative, corrupt, Cosmetic, costly, coverage, CP, created, Creek, criminal, cryopreservation, cryopreserve, cryopreserved, cultural, curtail, cyber, cybersecurity, damage, damaged, debarment, decide, decision, deficiency, degrade, delisted, Delisting, demonstrate, denominated, deny, Department, depletion, desire, desired, device, devise, devote, DGCL, differentiate, differentiation, difficult, difficulty, diligence, diligently, director, disable, discarded, discontinuance, discontinue, discontinued, discourage, discouraging, discovered, discovery, disgorgement, dispersion, disposal, dispose, disposing, disrupt, disrupted, disruption, distance, distancing, diverse, diversification, diversion, divert, divided, division, documentation, documented, dollar, donated, donation, double, downturn, drug, duly, duration, duty, earlier, earnest, economy, efficacy, effort, electronic, element, eligibility, Eligible, eliminate, eliminated, embedded, Emory, encapsulated, encounter, encountered, encourage, energy, enhance, enhanced, entail, enumerated, environmental, eradicate, ESG, essential, ethnically, European, evidencing, evolution, evolve, evolving, exceed, exempt, exemption, exert, expend, export, exportation, exported, expose, exposed, exposure, expressed, external, externally, extravault, extremely, face, facilitated, fat, favor, favorable, FCPA, federal, feet, fifteen, fifty, fight, fill, final, fire, firm, FL, float, flood, Food, foot, formal, formulated, fortification, forum, found, Foundation, Founded, freely, freezer, frequently, fuel, furnish, Gene, governmental, grow, GTP, hand, harder, hardware, harm, harmed, harmful, harvested, heading, healing, healthcare, healthy, heightened, Hematopoietic, hereinafter, high, HIPAA, HITECH, hosted, hostile, hosting, house, HRSA, human, hypothetical, image, immune, implicated, impose, imposed, imprisonment, inadvertently, inconclusive, incorrect, increasingly, IND, indemnification, indemnify, independent, indirect, indirectly, indispensable, industrial, industry, infection, inflammation, inflation, influence, influencing, infrastructure, infringe, infringement, infringing, inhibit, injury, innovation, inspect, inspection, insufficient, intense, interference, internationally, internet, interruption, intervention, investigate, investigational, investor, IRB, Jersey, judgement, key, knee, knowingly, labeled, labeling, labor, lack, land, language, large, larger, law, lead, leadership, legislation, legislative, lengthy, lesser, leverage, lieu, LLC, lose, low, macroeconomic, magnitude, malfeasance, Maryland, match, matched, maximum, meaningful, media, medicine, mentioned, merchant, merger, merit, mesenchymal, metastasized, Michigan, Minnesota, misbranding, misperception, mission, misstatement, misuse, monetary, mortgage, motivate, MSC, multiyear, Nasdaq, NDA, network, neural, neurological, newborn, nonclinical, noncompliance, nongovernmental, nonvoting, notice, notification, notwithstanding, nucleated, Occupational, oEqual, official, oil, ongoing, online, operationally, opportunity, opposition, organizational, OSHA, overallotment, overlap, overseeing, oversight, owner, oxygen, page, parent, Park, partial, partially, participating, party, patient, pediatric, penetration, perception, perfect, peripheral, pertaining, pharmaceutical, PHS, pill, placebo, placenta, PMA, poison, policy, political, Portability, portal, power, precautionary, precedent, preclinical, preferred, pregnant, premarket, prenatal, prescribed, primary, privacy, proceeding, procured, procurement, produce, prohibitive, prolonged, promote, promoted, promotional, proof, proper, properly, proposed, protect, protecting, protection, protectionist, prove, push, quotient, radiation, range, ranging, ransomware, rapid, ratio, readout, reagent, Recap, recession, recoup, recruiting, red, redundant, referral, reform, regain, regional, register, registered, registration, registry, reimbursed, reimbursement, Reinvestment, rejection, rely, relying, remediate, repair, repeat, replacing, request, resistance, resolve, resolved, respond, response, responsible, resurgence, revolutionary, rich, robust, roof, rumored, run, sabotage, safe, safety, satisfactorily, save, saving, Scannell, screening, scrutiny, secondary, secrete, secure, security, set, sharp, shortfall, show, sibling, simplified, simply, single, site, situation, size, slower, slowly, small, social, solution, sought, sponsor, square, stockholder, stop, strain, stringent, stromal, strong, submission, submit, submitted, Subpart, suffer, Suite, summer, superior, superseded, susceptible, suspend, suspended, Tainhe, takeover, Tampa, target, targeted, team, telemarketing, telephone, tender, tendered, thaw, thawed, thawing, therapy, thereunder, threatened, tighter, title, TNC, Today, transmission, travel, treat, treated, treating, Triangle, turn, unable, unacceptable, unannounced, unauthorized, unaware, undergo, underwriter, unemployment, unethical, unexpected, unfair, unforeseen, uninterrupted, Union, unmarketable, vaccine, validity, variety, vast, vendor, view, violate, violation, vote, voting, vulnerable, war, warning, Washington, waste, web, website, welfare, wheat, white, wholly, wide, widespread, worldwide, York
Removed:
aforementioned, Alternatively, annually, buying, capitalization, Consistent, crediting, declining, deficit, delivery, deregistration, Emergency, established, exhaustion, expired, extend, fiduciary, iv, ix, package, Pakistan, par, principally, projected, proxy, reached, seller, therefrom, unpaid, vi, vii, viii, weighted, worth, xi, xii, xiii, xiv, xix, xv, xvi, xvii, xviii, xx, xxi, xxii, xxiii, xxiv, xxv, xxvi, xxvii, xxviii
Financial reports
Current reports
8-K
Cord Blood Banking Leader Cryo-cell Announces Extravault Biorepository Service
16 Mar 22
8-K
Results of Operations and Financial Condition
24 Feb 22
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
25 Jan 22
8-K
Departure of Directors or Certain Officers
15 Dec 21
8-K
Submission of Matters to a Vote of Security Holders
25 Oct 21
8-K
CORD BLOOD BANKING LEADER CRYO-CELL REPORTS FISCAL THIRD Quarter 2021 FINANCIAL RESULTS
15 Oct 21
8-K
Cryo-Cell International Announces Changes To Its Board of Directors
22 Sep 21
8-K
Departure of Directors or Certain Officers
4 Aug 21
8-K
CORD BLOOD BANKING LEADER CRYO-CELL REPORTS FISCAL SECOND Quarter 2021 FINANCIAL RESULTS
19 Jul 21
8-K
Departure of Directors or Certain Officers
30 Jun 21
Registration and prospectus
S-1/A
IPO registration (amended)
27 Apr 22
S-1
IPO registration
4 Apr 22
8-A12B
Registration of securities on exchange
26 Aug 21
SC TO-I/A
Issuer tender offer statement (amended)
29 Jul 15
SC TO-I
Issuer tender offer statement
29 Jun 15
S-8
Registration of securities for employees
16 Jul 14
S-8
Registration of securities for employees
26 Dec 11
S-8
Registration of securities for employees
18 Jul 01
S-8
Registration of securities for employees
29 May 01
S-8
Registration of securities for employees
15 Jun 00
Other
CERT
Certification of approval for exchange listing
30 Aug 21
UPLOAD
Letter from SEC
9 Sep 20
CORRESP
Correspondence with SEC
7 Sep 20
UPLOAD
Letter from SEC
12 Jul 20
UPLOAD
Letter from SEC
11 Dec 13
CORRESP
Correspondence with SEC
5 Dec 13
UPLOAD
Letter from SEC
20 Nov 13
CORRESP
Correspondence with SEC
15 Jul 12
CORRESP
Correspondence with SEC
5 Jul 12
UPLOAD
Letter from SEC
1 Jul 12
Ownership
4/A
CRYO CELL INTERNATIONAL / DAVID PORTNOY ownership change
14 Apr 22
4/A
CRYO CELL INTERNATIONAL / Mark L. Portnoy ownership change
14 Apr 22
SC 13G/A
CRYO CELL INTERNATIONAL / ISZO CAPITAL ownership change
14 Feb 22
4/A
CRYO CELL INTERNATIONAL / Mark L. Portnoy ownership change
8 Feb 22
4/A
CRYO CELL INTERNATIONAL / DAVID PORTNOY ownership change
8 Feb 22
4
CRYO CELL INTERNATIONAL / Oleg Mikulinsky ownership change
29 Dec 21
4
CRYO CELL INTERNATIONAL / Oleg Mikulinsky ownership change
28 Dec 21
4
CRYO CELL INTERNATIONAL / Mark L. Portnoy ownership change
27 Dec 21
4
CRYO CELL INTERNATIONAL / DAVID PORTNOY ownership change
27 Dec 21
4
CRYO CELL INTERNATIONAL / Harold D. Berger ownership change
21 Oct 21
Reddit threads
Daily Discussion Thread - April 13th, 2022
13 Apr 22
Daily Discussion Thread - April 12th, 2022
12 Apr 22
Daily Discussion Thread - April 11th, 2022
11 Apr 22
Daily Discussion Thread - February 23rd, 2022
23 Feb 22
Daily Discussion Thread - February 22nd, 2022
22 Feb 22
Daily Discussion Thread - February 21st, 2022
21 Feb 22